Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
Filter by Categories

Series B

Nature's Fynd unearths $80m
The Montana State University-backed edible protein developer has rebranded from Sustainable Bioproducts and received series B funding.
Nurix nabs $120m
UC Berkeley's Nurix Therapeutics will use the capital to prepare two protein modulation-based immuno-oncology drugs for the clinic.
Circle Pharma rings up $45m
Circle Pharma, a spinout of UCSF and UC Santa Cruz, has collected series B funding from investors including another UC campus, Berkeley.
Harbour BioMed collects $75m
Humanised antibody-based drug developer Harbour BioMed has now raised $210m altogether following a series B-plus round featuring Zhejiang University Future Capital.
Immunocore imports $130m in series B round
Eli Lilly and WuXi AppTec contributed to what was reportedly a down round for T-cell oncology treatment developer Immunocore following a $320m raise in 2015.
Tricog pinpoints $10.5m
University of Tokyo Edge Capital has returned to invest in AI-assisted cardiac diagnosis technology developer Tricog Health.
Daily deal net: February 20, 2020
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Concirrus burrows away $20m
Insurance underwriting software business Concirrus raised capital to fund product enhancements and entry into new verticals and geographies.

Other News

Stilla sets up $21.8m series B
Paris Saclay Seed Fund and all other existing backers returned for the series B round, which additionally attracted Tsinghua University’s TUS Holdings.
BenchSci sits down investors to raise $22m
Existing investor Gradient Ventures invested in a series B round that almost doubled the clinical research software provider's overall funding to $45m.
IDbyDNA dials in $20m
Utah-founded metagenomic evaluation platform developer IDbyDNA has now raised at least $29m, with the latest round to support continued commercialisation.
SetSquared Bristol portfolio raises $85m
The University of Bristol-led incubator now has more than 80 portfolio companies, which posted a combined turnover of $77m during 2019.
Mammoth evolves with $45m series B
Verily has taken part in an oversubscribed series B round that will fund the UC Berkeley spinout's expansion from diagnostics to gene editing and drug development.
Skylo escapes stealth with $116m
SoftBank has led a $103m series B round for the IoT network and hub developer, a spinout of Stanford, that made up one of two rounds it has raised.

Editor's Picks

Big deal: Ribon ties together $65m series B
Ribon Therapeutics has emerged out of stealth after three years of developing a lead asset targeting cancer based on research at MIT, UT Southwestern and Harvard Medical School.
Canvas paints $9m picture
Canvas Network, an online education platform developed by learning management software (LMS) provider Instructure which received $9.1m investment for the platform, has begun offering free and open online courses.
WRF finds its Resolve
In May 2010, Resolve raised $2m in the initial close of its A round before bringing in a corporate venturing unit later.
Imperial helps PsiOxus raise $34m
UK-listed investment fund Imperial Innovations joins GlaxoSmithKline's SR One, fund manager Invesco Perpetual and Lundbeckfond Ventures, backing the d cancer treatment company.
test reg